Rheumatology

17-32 of 130

Navigating the Modern PsA Treatment Landscape
Navigating the Modern PsA Treatment Landscape
Living Rheum
Navigating the Modern PsA Treatment Landscape
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Living Rheum
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
- Steve Jackson, PharmD
- Marc Scherlinger, MD, PhD
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Living Rheum
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
- Ryan Quigley
- Luigi Adamo, MD, PhD
- Andrea Fava, MD
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Living Rheum
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
- Gary S. Firestein, MD
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Living Rheum
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
- Gary S. Firestein, MD
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
DermConsult
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living Rheum
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
- Ryan Quigley
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Living Rheum
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Living Rheum
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Preventing Bone Loss in Older Adults: Do Weighted Vests or Resistance Training Work?
Preventing Bone Loss in Older Adults: Do Weighted Vests or Resistance Training Work?
On the Frontlines of Osteoporosis
Preventing Bone Loss in Older Adults: Do Weighted Vests or Resistance Training Work?
- Ashley Baker, MSN, PMHNP
- Kristen Beavers, PhD, MPH, RD
Sjögren’s Disease Management: A Decade in Review
Sjögren’s Disease Management: A Decade in Review
Living Rheum
Sjögren’s Disease Management: A Decade in Review
Early Rituximab Use in Sjögren’s Syndrome: A Meta-Analysis Review
Early Rituximab Use in Sjögren’s Syndrome: A Meta-Analysis Review
Living Rheum
Early Rituximab Use in Sjögren’s Syndrome: A Meta-Analysis Review
GeneHarmony: Mapping Shared Genes in Autoimmune Disease
GeneHarmony: Mapping Shared Genes in Autoimmune Disease
Living Rheum
GeneHarmony: Mapping Shared Genes in Autoimmune Disease
Sjögren’s Disease Care: Diagnosis and Management Considerations
Sjögren’s Disease Care: Diagnosis and Management Considerations
Living Rheum
Sjögren’s Disease Care: Diagnosis and Management Considerations
- Nancy Carteron, MD
Connecting the Dots: Recognizing Systemic Clues in Sjögren’s Disease
Connecting the Dots: Recognizing Systemic Clues in Sjögren’s Disease
Living Rheum
Connecting the Dots: Recognizing Systemic Clues in Sjögren’s Disease
- Nancy Carteron, MD
Preventing Sjögren’s Complications: The Importance of Timely, Accurate Diagnosis
Preventing Sjögren’s Complications: The Importance of Timely, Accurate Diagnosis
Living Rheum
Preventing Sjögren’s Complications: The Importance of Timely, Accurate Diagnosis
- Nancy Carteron, MD

2/7

Rheumatology

17-32 of 130

CONTACT US

(866) 423-7849

CONTACT US

(866) 423-7849

17-32 of 130

Title